After AF3485 administration, EGFR phosphorylation was inhibited to an extent similar to that observed in AG1478 treated mice, substantiating the notion that endogenous mPGES-1-derived PGE2 fuels tumor growth by EGFR transactivation (Fig. 3B). This evidence concerns the gene EGFR and neoplasm.